Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

EGFR

  • You have access
    Co-targeting ER and HER Family Receptors Induces Apoptosis in HER2-normal or Overexpressing Breast Cancer Models
    ASHOK K. CHAKRABORTY, RANEE MEHRA and MICHAEL P. DIGIOVANNA
    Anticancer Research March 2015, 35 (3) 1243-1250;
  • You have access
    Detection of Circulating Tumor Cells in Bladder Cancer Using Multiplex PCR Assays
    IOANNIS LEOTSAKOS, PANAGIOTIS DIMOPOULOS, ELIONA GKIOKA, PAVLOS MSAOUEL, ADRIANOS NEZOS, KONSTANTINOS G. STRAVODIMOS, MICHAEL KOUTSILIERIS and CONSTANTINOS A. CONSTANTINIDES
    Anticancer Research December 2014, 34 (12) 7415-7424;
  • You have access
    Erlotinib Is a Well-tolerated Alternate Treatment for Non-small Cell Lung Cancer in Cases of Gefitinib-induced Hepatotoxicity
    KIMIO YONESAKA, TOMOHIRO SUZUMURA, HIROSHI TSUKUDA, YOSHIKAZU HASEGAWA, TOMOHIRO OZAKI, TAKAMUNE SUGIURA and MASAHIRO FUKUOKA
    Anticancer Research September 2014, 34 (9) 5211-5215;
  • You have access
    Detection of Circulating Tumor Cells in Colorectal and Gastric Cancer Using a Multiplex PCR Assay
    ARISTEIDIS G. VAIOPOULOS, IOANNIS D. KOSTAKIS, ELIONA GKIOKA, KALLIOPI CH. ATHANASOULA, EMMANOUIL PIKOULIS, ALEXANDROS PAPALAMBROS, PANAGIOTIS CHRISTOPOULOS, HELEN GOGAS, GREGORY KOURAKLIS and MICHAEL KOUTSILIERIS
    Anticancer Research June 2014, 34 (6) 3083-3092;
  • You have access
    Relationship Between EGFR Mutations and Clinicopathological Features of Lung Adenocarcinomas Diagnosed via Small Biopsies
    HYUN JUNG KIM, EUN YOUNG CHOI, HYUN JUNG JIN and KYEONG-CHEOL SHIN
    Anticancer Research June 2014, 34 (6) 3189-3195;
  • You have access
    COX2 Inhibitor NS398 Reduces HT-29 Cell Invasiveness by Modulating Signaling Pathways Mediated by EGFR and HIF1-α
    CLAUDIA BOCCA, FRANCESCA BOZZO and ANTONELLA MIGLIETTA
    Anticancer Research April 2014, 34 (4) 1793-1800;
  • You have access
    Melting Curve Analysis for Mutations of EGFR and KRAS
    KOH FURUGAKI, HIDEYUKI YASUNO, TOSHIKI IWAI, YOICHIRO MORIYA, NAOKI HARADA and KAORI FUJIMOTO-OUCHI
    Anticancer Research February 2014, 34 (2) 613-621;
  • You have access
    Expression of PDGFR-α, EGFR and c-MET in Spinal Chordoma: A Series of 52 Patients
    REZA AKHAVAN-SIGARI, MICHAEL ROBERT GAAB, VEIT ROHDE, MEHDI ABILI and HELMUT OSTERTAG
    Anticancer Research February 2014, 34 (2) 623-630;
  • You have access
    Epidermal Growth Factor Receptor (EGFR)-targeted Therapies in Esophagogastric Cancer
    SABARISH AYYAPPAN, DHIVYA PRABHAKAR and NEELESH SHARMA
    Anticancer Research October 2013, 33 (10) 4139-4155;
  • You have access
    Radiation-induced Dimer Formation of EGFR: Implications for the Radiosensitizing Effect of Cetuximab
    MAKOTO KIYOZUKA, TETSUO AKIMOTO, MIKA FUKUTOME, ATSUSHI MOTEGI and NORIO MITSUHASHI
    Anticancer Research October 2013, 33 (10) 4337-4346;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire